Woodcreek is reaching out to our patients directly via phone to communicate the details of the recall. This is a lengthy process so feel free to contact our office directly to obtain information on how to acquire a replacement product.
Our office is available to provide a substitution epinephrine product prescription to our current patients who have an AuVi-Q autoinjector. The Auvi-Q autoinjector will need to be replaced by another epinephrine product immediately. We understand that the new epinephrine product prescribed to you will be a different type of autoinjector and will require education and training. Please contact our Allergy/Asthma Clinic to schedule a training session specific to the new product at 253-848-8797.
Anyone who has questions regarding their AuVi-Q epinephrine autoinjector may utilize www.Auvi-Q.com for information, email@example.com or call 1-877-319-8963 (Monday throught Friday 8 a.m to 8 p.m ET). Sanofi will provide reimbursement for out of pockets costs incurred for the purchase of new epinephrine auto-injectors with proof of purchase.
As always, Woodcreek is here for you and your family. Please do not hesitate to contact our office with questions or concerns.